4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-26-028656
President/CEO acquired 20,175 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President/CEO | 2026-03-12 | Grant or award | +20,175 | 393,895 | D | ||
| Derivatives | |||||||
| Gilad Oren President/CEO | 2026-03-12 | Grant or award · Stock Options (Right to Buy) | +80,700 | 80,700 | D | ||
Loading xslF345X05/tm268953-2_4seq1.xml…